Zika virus infections

F de Laval1, I Leparc-Goffart2, J-B Meynard3

  • 1Centre d'épidémiologie et de santé publique des Armées, Camp militaire de Sainte-Marthe, BP 40026, 13568 Marseille cedex 02, France, Direction interarmées du service de santé en Guyane, Quartier La Madeleine, BP 6019, 97306 Cayenne cedex, Guyane française.

Insights

Zika virus (ZIKV) infection, initially discovered in 1947, has emerged as a global health concern, linked to neurological issues and microcephaly. This review covers ZIKV transmission, epidemiology, clinical features, diagnosis, treatment, and prevention.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Zika virus (ZIKV) was first identified in Uganda in 1947.
  • Sporadic outbreaks occurred in Micronesia (2007) and French Polynesia (2013-2014), with the latter noting neurological effects.
  • The virus gained global attention following its association with microcephaly in Brazil starting in 2015.

Purpose of the Study:

  • To provide a comprehensive overview of Zika virus (ZIKV) infection.
  • To synthesize current knowledge on ZIKV transmission, epidemiology, and clinical manifestations.
  • To discuss diagnostic, therapeutic, and preventive strategies for ZIKV.

Main Methods:

  • Literature review of ZIKV research.
  • Synthesis of epidemiological data.
  • Analysis of clinical case reports and public health declarations.

Main Results:

  • ZIKV outbreaks have increased in frequency and geographic scope.
  • A significant link exists between maternal ZIKV infection during pregnancy and congenital microcephaly.
  • The World Health Organization declared ZIKV a public health emergency in 2016.

Conclusions:

  • ZIKV poses a significant threat to global public health.
  • Continued research is crucial for understanding and combating ZIKV.
  • Effective prevention and control strategies are essential to mitigate the impact of ZIKV outbreaks.